Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study.

Saved in:
Bibliographic Details
Title: Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study.
Authors: Martiniano SL; Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: stacey.martiniano@childrenscolorado.org., Caceres SM; Department of Medicine, National Jewish Health, Denver, CO 80206, USA., Poch K; Department of Medicine, National Jewish Health, Denver, CO 80206, USA., Rysavy NM; Department of Medicine, National Jewish Health, Denver, CO 80206, USA., Lovell VK; Department of Medicine, National Jewish Health, Denver, CO 80206, USA., Armantrout E; Department of Medicine, National Jewish Health, Denver, CO 80206, USA., Jones M; Department of Medicine, National Jewish Health, Denver, CO 80206, USA., Anthony M; Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO 80045, USA., Keck A; Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO 80045, USA., Nichols DP; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington, USA., Vandalfsen JM; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington, USA., Sagel SD; Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO 80045, USA., Wagner B; Department of Biostatistics and Informatics, Colorado School of Public Health University of Colorado Anschutz Medical Campus Aurora Colorado, USA., Xie J; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington, USA., Weaver K; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington, USA., Heltshe SL; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington, USA., Daley CL; Department of Medicine, National Jewish Health, Denver, CO 80206, USA; Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA., Davidson RM; Center for Genes, Environment, and Health, National Jewish Health, Denver, CO 80206, USA., Nick JA; Department of Medicine, National Jewish Health, Denver, CO 80206, USA; Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Corporate Authors: Investigators of the Cystic Fibrosis NTM Consortium
Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2024 Jan; Vol. 23 (1), pp. 50-57. Date of Electronic Publication: 2023 Sep 04.
Publication Type: Multicenter Study; Observational Study; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5010 (Electronic) Linking ISSN: 15691993 NLM ISO Abbreviation: J Cyst Fibros Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-5010
DOI:10.1016/j.jcf.2023.08.007